About

Dr. P. Paparel is a leading urologic oncologist whose research centers on the surgical management of renal tumors, with a particular focus on comparing and refining partial nephrectomy techniques. His major contributions stem from his leadership in large-scale, multicenter studies within the French Kidney Cancer Research Network (UroCCR). He has been instrumental in demonstrating that robotic-assisted partial nephrectomy (RPN) offers comparable or superior outcomes to open surgery, even in complex cases like solitary kidneys and T1b tumors, as shown in his highly cited 2022 UroCCR-47 study (46 citations). His work also extends to vulnerable populations, including elderly patients and those requiring imperative treatment, where he has evaluated the safety and efficacy of RPN versus ablative therapies. With multiple papers exceeding 20 citations and a 2024 study on hilar masses (NEPRAH, UroCCR 175), Dr. Paparel’s research provides crucial, contemporary evidence guiding surgical decision-making and advancing the adoption of minimally invasive techniques in kidney cancer care.

Research Focus

Key Achievements

10
H-Index
15
Papers
251
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Comparison of open and robotic-assisted partial nephrectomy approaches using multicentric data (UroCCR-47 study)
46 citations · 2022
📈 Most Prolific Year: 2022 (3 Papers)
🤝 Key Collaborators: 137
🏛 Institutions: Hospices Civils de Lyon, Lymphoma Study Association, Hôpital Lyon Sud, Université Claude Bernard Lyon 1, Memorial Sloan Kettering Cancer Center, Université de Lyon

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago